4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
12.25 USD
↗ 0.02 (0.16%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $12.25. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$12.25
High?$12.25
Low?$12.25
Prev. Close?$12.23
Volume?0
Avg. Volume?999.8K
Bid / Ask
Bid?$9.82 × 100
Ask?$14.05 × 100
Spread?$4.23
Midpoint?$11.94
Valuation & Ratios
Market Cap?689.5M
Shares Out?56.4M
Float?53.3M
Float %?96.6%
P/E Ratio?N/A
P/B Ratio?1.69
EPS?-$3.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Employees
196
Market Cap
689.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
39
Momentum?
48
Short Sent.?
44
Piotroski F-Score?1/9Weak
Altman Z-Score?2.11Grey
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?20.43%Squeeze Risk
Short Interest?10.9M
Days to Cover?10.4
Free Float53.3M
Avg Daily Volume1.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?8.03Strong
Quick Ratio?8.03Strong
Cash Ratio?1.48Strong
Debt/Equity?0.05Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
83
1.69CHEAP▾
P/S?
Peers
100
S&P
15
7.49HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.3CHEAP▾
EV/Sales?
Peers
100
S&P
20
6.94HIGH▾
Returns & Efficiency
ROE?
S&P
3
-44.0%WEAK▾
ROA?
S&P
3
-36.4%WEAK▾
Cash Flow & Enterprise
FCF?$-156177000
Enterprise Value?$638.7M
Fundamentals ratios updated end of day